Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelastine (MP03-36 and MP03-33) in Perennial Allergic Rhinitis
NCT00712920Phase 3Completed
- Sponsor
- Meda
- Start
- Jan 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azelastine in perennial allergic rhinitis (PAR), sponsored by Meda. Started Jan 2007; status: completed.
02
Drugs
azelastine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00712920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00712920.